Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Sustained Release Excipients Industry?

Over the past few years, the market size for sustained release excipients has been experiencing significant growth. An increase from $1.4 billion in 2024 to $1.51 billion in 2025 is projected, representing a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period is due to factors including a rise in demand for controlled drug release, the prevalence of chronic diseases, better patient compliance and convenience, innovations in the pharmaceutical industry, and regulatory support for extended-release formulations.

The market size of sustained release excipients is projected to witness significant expansion in the approaching years. Its value is anticipated to reach “$2.1 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.5%.” Factors influencing growth during the forecast period are an aging global population, emphasis on customized healthcare, hurdles in patient compliance, rise in sophisticated drug formulations, progression in disease control, and the expansion of healthcare worldwide. Key trends in the forecast period incorporate patient-focused drug delivery, partnerships for formulation development, adherence to regulatory mandates and safety, global growth of drug formulation technologies, and the impact of biopharmaceuticals.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

What Forces Are Driving The Growth Of The Sustained Release Excipients Industry?

The sustained-release excipients market is poised to experience growth, thanks to the rising incidence of chronic and acute diseases. Chronic illnesses are medical conditions that last longer – usually three months or more, while acute diseases are typically intense but short-lived, lasting only a few hours to days or weeks. Sustained-release excipients, common in the formulation of pharmaceutical products for both disease types, has benefits like improving patient adherence, maintaining uniform drug levels, minimizing side effects, and bettering disease management, thereby enhancing sales. As per the World Health Organization (WHO) in September 2022, the maximum NCD deaths – 17.9 million annually, were due to cardiovascular diseases, followed by chronic respiratory diseases (4.1 million), diabetes-related complications including kidney disease (2.0 million), and cancer (9.3 million). In August 2022, a report from the American College of Cardiology predicted that all major cardiovascular risk factors in the United States would see an upward trend from 2025 to 2060, with diabetes showing the highest percentage increase of 39.3% to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Also, cardiovascular disease rates for stroke and heart failure are expected to significantly increase (33.8% to 15 million and 33.4% to 13 million respectively), with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) also showing a marked increase. Thus, the escalating incidence of chronic and acute diseases is a significant factor driving the sustained-release excipients market’s growth.

The sustained release excipients market covered in this report is segmented –

1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan

2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration

3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation

Subsegments:

1) By Gelatin: Type A Gelatin, Type B Gelatin

2) By Polymers: Natural Polymers, Synthetic Polymers

3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients

4) By Sugars: Sucrose, Lactose, Glucose, Other Sugars

5) By Alcohol: Ethanol, Isopropyl Alcohol, Other Alcohols

6) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan

Which Emerging Trends And Strategic Shifts Are Shaping The Sustained Release Excipients Market?

One significant trend that is resurfacing in the sustained release excipients marketplace is product innovation. Key players in the market are designing and launching innovative products to cement their competitive place. For instance, Nutriventia Limited, a pharmaceutical firm based in India, introduced Prolanza, a sustained-release ashwagandha ingredient (Withania somnifera) in September 2022. Serving as an advance root-only extract of Ashwagandha, it provides an uninterrupted stress-reducing system. The exceptional release mechanism of Prolanza allows it to extend therapeutic effects over a prolonged duration with a single daily dosage. Compared to the control component, it showed superior relative absorption, enhanced bioavailability, and an extended elimination half-life, pointing to a prolonged-release pattern. Given that Ashwagandha is used primarily for its stress-relieving properties, Prolanza’s therapeutic benefits will last longer and provide boosted overall health benefits. It is derived from natural herbs and its effectiveness has been clinically validated.

Who Are The Primary Players Operating Across The Global Sustained Release Excipients Market?

Major companies operating in the sustained release excipients market include BASF SE, Ashland Global Holdings Inc., Colorcon Inc., Croda International Plc, Dow Chemical Company, DuPont de Nemours Inc., Roquette Frères, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, JRS Pharma GmbH & Co. KG, Shin-Etsu Chemical Co.Ltd., Gattefossé SAS, Eastman Chemical Company, Cellulose Solutions Private Limited, Avantor Inc., SPI Pharma Inc., Asahi Kasei Corporation, Chemische Fabrik Budenheim KG, Associated British Foods plc, Ransom Naturals Ltd, Balchem Corporation, IMCD Group, Lonza Group AG

https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

Which Region Offers The Most Growth Potential For The Sustained Release Excipients Market Through 2029?

North America was the largest region in the global sustained release excipients market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10822&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model